USP28抑制糖尿病心脏线粒体形态功能缺陷与心功能障碍
研究在db/db和高脂饮食/链脲佐菌素诱导的2型糖尿病小鼠及体外高糖加棕榈酸细胞模型中,发现糖尿病心脏USP28表达降低;USP28敲除加重心功能障碍和线粒体损伤,而过表达改善收缩舒张功能、减轻脂质沉积和线粒体缺陷,机制涉及USP28去泛素化稳定PPARα促进Mfn2转录。
要点
- 糖尿病心脏中USP28表达显著降低,且与心功能障碍相关。
- USP28过表达可改善糖尿病小鼠收缩和舒张功能,减轻心肌肥厚和纤维化。
- USP28通过去泛素化稳定PPARα(Lys152)促进Mfn2转录,维护线粒体功能。
核心结论
- USP28通过PPARα-Mfn2轴调控糖尿病心脏线粒体稳态,其激活或AAV靶向治疗可能成为糖尿病心肌病潜在策略。
研究设计与样本
- 采用db/db瘦素受体缺陷小鼠和高脂饮食/链脲佐菌素诱导的2型糖尿病小鼠模型。
- 在db/db背景构建心脏特异性USP28敲除小鼠(Myh6-Cre+/USP28fl/fl)。
- 向db/db小鼠注射携带USP28的AAV9(心肌肌钙蛋白T启动子)。
- 体外使用高糖加棕榈酸孵育的新生大鼠心室肌细胞和人诱导多能干细胞来源心肌细胞。
- 通过RNA测序、免疫沉淀与质谱、染色质免疫沉淀测序、蛋白pull-down等探索机制。
主要发现
- 基于db/db小鼠心脏和糖尿病患者心脏的UPS微阵列分析显示糖尿病心室USP28表达显著降低。
- 糖尿病Myh6-Cre+/USP28fl/fl小鼠较对照表现出更严重的进行性心功能障碍、脂质蓄积和线粒体排列紊乱。
- USP28过表达改善糖尿病心脏收缩和舒张功能障碍,减轻心肌肥厚和纤维化。
- AAV9-USP28糖尿病小鼠心脏脂质储存减少、活性氧形成降低、线粒体损伤减轻。
- USP28直接与PPARα相互作用,去泛素化并稳定PPARα(Lys152),促进Mfn2转录,从而阻止线粒体形态功能缺陷。
关键数值与推荐
- 在db/db小鼠中敲除PPARα或条件性失活Mfn2后,USP28的心脏保护作用大部分被消除。
临床怎么用
- USP28激活或AAV介导的USP28过表达可能作为糖尿病心肌病的治疗方向,但尚需临床验证。
局限性
- 研究主要基于小鼠模型和体外细胞实验,尚未在人体中验证USP28疗法的安全性和有效性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The majority of people with diabetes are susceptible to cardiac dysfunction and heart failure, and conventional drug therapy cannot correct diabetic cardiomyopathy progression. Herein, we assessed the potential role and therapeutic value of USP28 (ubiquitin-specific protease 28) on the metabolic vulnerability of diabetic cardiomyopathy. METHODS: The type 2 diabetes mouse model was established using db/db leptin receptor-deficient mice and high-fat diet/streptozotocin-induced mice. Cardiac-specific knockout of USP28 in the db/db background mice was generated by crossbreeding db/m and Myh6-Cre+/USP28fl/fl mice. Recombinant adeno-associated virus serotype 9 carrying USP28 under cardiac troponin T promoter was injected into db/db mice. High glucose plus palmitic acid-incubated neonatal rat ventricular myocytes and human induced pluripotent stem cell-derived cardiomyocytes were used to imitate diabetic cardiomyopathy in vitro. The molecular mechanism was explored through RNA sequencing, immunoprecipitation and mass spectrometry analysis, protein pull-down, chromatin immunoprecipitation sequencing, and chromatin immunoprecipitation assay. RESULTS: Microarray profiling of the UPS (ubiquitin-proteasome system) on the basis of db/db mouse hearts and diabetic patients' hearts demonstrated that the diabetic ventricle presented a significant reduction in USP28 expression. Diabetic Myh6-Cre+/USP28fl/fl mice exhibited more severe progressive cardiac dysfunction, lipid accumulation, and mitochondrial disarrangement, compared with their controls. On the other hand, USP28 overexpression improved systolic and diastolic dysfunction and ameliorated cardiac hypertrophy and fibrosis in the diabetic heart. Adeno-associated virus serotype 9-USP28 diabetic mice also exhibited less lipid storage, reduced reactive oxygen species formation, and mitochondrial impairment in heart tissues than adeno-associated virus serotype 9-null diabetic mice. As a result, USP28 overexpression attenuated cardiac remodeling and dysfunction, lipid accumulation, and mitochondrial impairment in high-fat diet/streptozotocin-induced type 2 diabetes mice. These results were also confirmed in neonatal rat ventricular myocytes and human induced pluripotent stem cell-derived cardiomyocytes. RNA sequencing, immunoprecipitation and mass spectrometry analysis, chromatin immunoprecipitation assays, chromatin immunoprecipitation sequencing, and protein pull-down assay mechanistically revealed that USP28 directly interacted with PPARα (peroxisome proliferator-activated receptor α), deubiquitinating and stabilizing PPARα (Lys152) to promote Mfn2 (mitofusin 2) transcription, thereby impeding mitochondrial morphofunctional defects. However, such cardioprotective benefits of USP28 were largely abrogated in db/db mice with PPARα deletion and conditional loss-of-function of Mfn2. CONCLUSIONS: Our findings provide a USP28-modulated mitochondria homeostasis mechanism that involves the PPARα-Mfn2 axis in diabetic hearts, suggesting that USP28 activation or adeno-associated virus therapy targeting USP28 represents a potential therapeutic strategy for diabetic cardiomyopathy.
引用
- Xie SY, Liu SQ, Zhang T, et al. USP28 Serves as a Key Suppressor of Mitochondrial Morphofunctional Defects and Cardiac Dysfunction in the Diabetic Heart. Circulation. 2023. PMID: 37994595. doi:10.1161/CIRCULATIONAHA.123.065603
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。